The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Oral Rabies Vaccine Market Research Report 2024
Synopsis
Global Oral Rabies Vaccine market is projected to reach US$ 297 million in 2029, increasing from US$ 80 million in 2022, with the CAGR of 20.3% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Oral Rabies Vaccine market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Oral Rabies Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Boehringer Ingelheim(Merial)
Ceva Santé Animale(Artemis Technologies)
Virbac
Segment by Type
Modified Live Virus
Recombinant Vaccinia
Recombinant Adenovirus Vaccine
Segment by Application
Government
Commercial
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Oral Rabies Vaccine report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Global Oral Rabies Vaccine market is projected to reach US$ 297 million in 2029, increasing from US$ 80 million in 2022, with the CAGR of 20.3% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Oral Rabies Vaccine market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Oral Rabies Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Boehringer Ingelheim(Merial)
Ceva Santé Animale(Artemis Technologies)
Virbac
Segment by Type
Modified Live Virus
Recombinant Vaccinia
Recombinant Adenovirus Vaccine
Segment by Application
Government
Commercial
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Oral Rabies Vaccine report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Oral Rabies Vaccine Market Overview
1.1 Product Overview and Scope of Oral Rabies Vaccine
1.2 Oral Rabies Vaccine Segment by Type
1.2.1 Global Oral Rabies Vaccine Market Value Comparison by Type (2023-2029)
1.2.2 Modified Live Virus
1.2.3 Recombinant Vaccinia
1.2.4 Recombinant Adenovirus Vaccine
1.3 Oral Rabies Vaccine Segment by Application
1.3.1 Global Oral Rabies Vaccine Market Value by Application: (2023-2029)
1.3.2 Government
1.3.3 Commercial
1.4 Global Oral Rabies Vaccine Market Size Estimates and Forecasts
1.4.1 Global Oral Rabies Vaccine Revenue 2018-2029
1.4.2 Global Oral Rabies Vaccine Sales 2018-2029
1.4.3 Global Oral Rabies Vaccine Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Oral Rabies Vaccine Market Competition by Manufacturers
2.1 Global Oral Rabies Vaccine Sales Market Share by Manufacturers (2018-2023)
2.2 Global Oral Rabies Vaccine Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Oral Rabies Vaccine Average Price by Manufacturers (2018-2023)
2.4 Global Oral Rabies Vaccine Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Oral Rabies Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oral Rabies Vaccine, Product Type & Application
2.7 Oral Rabies Vaccine Market Competitive Situation and Trends
2.7.1 Oral Rabies Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Oral Rabies Vaccine Players Market Share by Revenue
2.7.3 Global Oral Rabies Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Oral Rabies Vaccine Retrospective Market Scenario by Region
3.1 Global Oral Rabies Vaccine Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Oral Rabies Vaccine Global Oral Rabies Vaccine Sales by Region: 2018-2029
3.2.1 Global Oral Rabies Vaccine Sales by Region: 2018-2023
3.2.2 Global Oral Rabies Vaccine Sales by Region: 2024-2029
3.3 Global Oral Rabies Vaccine Global Oral Rabies Vaccine Revenue by Region: 2018-2029
3.3.1 Global Oral Rabies Vaccine Revenue by Region: 2018-2023
3.3.2 Global Oral Rabies Vaccine Revenue by Region: 2024-2029
3.4 North America Oral Rabies Vaccine Market Facts & Figures by Country
3.4.1 North America Oral Rabies Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Oral Rabies Vaccine Sales by Country (2018-2029)
3.4.3 North America Oral Rabies Vaccine Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Oral Rabies Vaccine Market Facts & Figures by Country
3.5.1 Europe Oral Rabies Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Oral Rabies Vaccine Sales by Country (2018-2029)
3.5.3 Europe Oral Rabies Vaccine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oral Rabies Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Oral Rabies Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Oral Rabies Vaccine Sales by Country (2018-2029)
3.6.3 Asia Pacific Oral Rabies Vaccine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Oral Rabies Vaccine Market Facts & Figures by Country
3.7.1 Latin America Oral Rabies Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Oral Rabies Vaccine Sales by Country (2018-2029)
3.7.3 Latin America Oral Rabies Vaccine Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Oral Rabies Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Oral Rabies Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Oral Rabies Vaccine Sales by Country (2018-2029)
3.8.3 Middle East and Africa Oral Rabies Vaccine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Oral Rabies Vaccine Sales by Type (2018-2029)
4.1.1 Global Oral Rabies Vaccine Sales by Type (2018-2023)
4.1.2 Global Oral Rabies Vaccine Sales by Type (2024-2029)
4.1.3 Global Oral Rabies Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Oral Rabies Vaccine Revenue by Type (2018-2029)
4.2.1 Global Oral Rabies Vaccine Revenue by Type (2018-2023)
4.2.2 Global Oral Rabies Vaccine Revenue by Type (2024-2029)
4.2.3 Global Oral Rabies Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Oral Rabies Vaccine Price by Type (2018-2029)
5 Segment by Application
5.1 Global Oral Rabies Vaccine Sales by Application (2018-2029)
5.1.1 Global Oral Rabies Vaccine Sales by Application (2018-2023)
5.1.2 Global Oral Rabies Vaccine Sales by Application (2024-2029)
5.1.3 Global Oral Rabies Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Oral Rabies Vaccine Revenue by Application (2018-2029)
5.2.1 Global Oral Rabies Vaccine Revenue by Application (2018-2023)
5.2.2 Global Oral Rabies Vaccine Revenue by Application (2024-2029)
5.2.3 Global Oral Rabies Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Oral Rabies Vaccine Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Boehringer Ingelheim(Merial)
6.1.1 Boehringer Ingelheim(Merial) Corporation Information
6.1.2 Boehringer Ingelheim(Merial) Description and Business Overview
6.1.3 Boehringer Ingelheim(Merial) Oral Rabies Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Boehringer Ingelheim(Merial) Oral Rabies Vaccine Product Portfolio
6.1.5 Boehringer Ingelheim(Merial) Recent Developments/Updates
6.2 Ceva Santé Animale(Artemis Technologies)
6.2.1 Ceva Santé Animale(Artemis Technologies) Corporation Information
6.2.2 Ceva Santé Animale(Artemis Technologies) Description and Business Overview
6.2.3 Ceva Santé Animale(Artemis Technologies) Oral Rabies Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Ceva Santé Animale(Artemis Technologies) Oral Rabies Vaccine Product Portfolio
6.2.5 Ceva Santé Animale(Artemis Technologies) Recent Developments/Updates
6.3 Virbac
6.3.1 Virbac Corporation Information
6.3.2 Virbac Description and Business Overview
6.3.3 Virbac Oral Rabies Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Virbac Oral Rabies Vaccine Product Portfolio
6.3.5 Virbac Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oral Rabies Vaccine Industry Chain Analysis
7.2 Oral Rabies Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oral Rabies Vaccine Production Mode & Process
7.4 Oral Rabies Vaccine Sales and Marketing
7.4.1 Oral Rabies Vaccine Sales Channels
7.4.2 Oral Rabies Vaccine Distributors
7.5 Oral Rabies Vaccine Customers
8 Oral Rabies Vaccine Market Dynamics
8.1 Oral Rabies Vaccine Industry Trends
8.2 Oral Rabies Vaccine Market Drivers
8.3 Oral Rabies Vaccine Market Challenges
8.4 Oral Rabies Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
